References
- Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 1997; 51:337–361., [PUBMED], [INFOTRIEVE], [CSA]
- Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Yamane Y. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab 1977; 44(5):1014–1017., [PUBMED], [INFOTRIEVE]
- Shannon M W, Quang L S. Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. Pediatr Emerg Care 2000; 16(6):435–440., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zvosec D L, Smith S W, McCutcheon J R, Spillane J, Hall B J, Peacock E A. Adverse events, including death, associated with the use of 1,4-butanediol. N Engl J Med 2001; 344(2):87–94., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tancredi D N, Shannon M S. Case 30-2003: a 21-year-old man with sudden alteration of mental status. N Engl J Med 2003; 349:1267–1275., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Http://www.usdoj.gov/dea/deadiversion/fed_regs/sched_actions/2000/fr0313.html, , (accessed July 2001).
- Http://www.nida.nih.gov/CEWG/AdvancedRep/601adv.html, , (accessed August 2001).
- Quang L S, Desai M C, Kraner J C, Shannon M W, Woolf A D, Maher T J. Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor, 1,4-butanediol, in CD-1 mice. Ann N Y Acad Sci 2001; 965:461–472., [CSA]
- Quang L S, Shannon M W, Desai M C, Woolf, A D, Maher T J. Pretreatment of CD-1 mice with 4-methylpyrazole blocks toxicity from the gamma-hydroxybutyrate precursor, 1,4-butanediol. Life Sci 2002; 71(7):771–778., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Quang L S, Desai M C, Shannon M W, Woolf A D, Maher T J. 4-Methylpyrazole decreases 1,4-butanediol toxicity by blocking its in vivo biotransformation to gamma-hydroxybutyric acid. Ann N Y Acad Sci 2004; 1025:528–537., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]